May 22, 2018 8:53 AM ET


Company Overview of Navitas Pharma, Inc.

Company Overview

Navitas Pharma, Inc. is a clinical-stage pharmaceutical company that focuses on developing drugs for cardiovascular and liver disorders. The company offers a drug for the treatment of endothelial dysfunction, as well as associated diseases, including pulmonary hypertension, systemic hypertension, diabetes, high lipids, and claudication. It offers its products in the United States and Europe. The company was founded in 2003 and is based in Laramie, Wyoming with additional offices in Manhattan, New York; Palo Alto, California; and Provo, Utah. As of May 29, 2008, Navitas Pharma, Inc. operates as a subsidiary of Gilead Sciences Inc.

3120 Hayford Avenue

Laramie, WY 82072

United States

Founded in 2003



Key Executives for Navitas Pharma, Inc.

Chief Executive Officer
Founder and Senior Advisor
Age: 89
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
Praetego, Inc. United States
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Navitas Pharma, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at